HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianqing Zhu Selected Research

Jianqing Zhu Research Topics

Disease

17Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 04/2013
15Neoplasms (Cancer)
10/2022 - 04/2013
7Disease Progression
12/2022 - 01/2020
4Ovarian Epithelial Carcinoma
01/2022 - 04/2013
3Carcinoma (Carcinomatosis)
07/2022 - 09/2020
3Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2021 - 07/2015
3Infections
12/2018 - 10/2014
2Nausea
12/2022 - 01/2021
2Anemia
12/2022 - 01/2021
2Neoplasm Metastasis (Metastasis)
07/2022 - 10/2015
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2022
1Residual Neoplasm
10/2021
1Cadmium Poisoning (Itai Itai)
04/2021
1Poisoning
04/2021
1Leukopenia
01/2021
1Ascites
01/2021
1Neutropenia
01/2021
1Fallopian Tube Neoplasms
09/2020
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
09/2020
1Disease Resistance
05/2020
1Cytokine Release Syndrome
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Hypochromic Anemia (Chlorosis)
12/2019
1Carcinogenesis
01/2019
1Endometrial Neoplasms (Endometrial Cancer)
01/2019
1Thrombocytosis (Thrombocythemia)
06/2017
1Stomach Neoplasms (Stomach Cancer)
01/2017
1Thrombocytopenia (Thrombopenia)
10/2015
1Pain (Aches)
10/2015
1Hemorrhage
10/2015
1Multiple Organ Failure (MODS)
10/2015
1Genetic Predisposition to Disease (Genetic Predisposition)
07/2015

Drug/Important Bio-Agent (IBA)

11PlatinumIBA
12/2022 - 04/2013
3olaparibIBA
12/2022 - 01/2021
3niraparibIBA
01/2022 - 01/2020
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 01/2021
3Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2018
2Immune Checkpoint InhibitorsIBA
10/2022 - 01/2022
2fluzoparibIBA
01/2022 - 01/2021
2AntioxidantsIBA
04/2021 - 12/2019
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2019
2Mitochondrial DNA (mtDNA)IBA
12/2018 - 10/2014
2MicroRNAs (MicroRNA)IBA
06/2018 - 01/2017
1Poly Adenosine Diphosphate RiboseIBA
12/2022
1Immunoglobulin G (IgG)IBA
10/2022
1penpulimabIBA
10/2022
1Programmed Cell Death 1 ReceptorIBA
07/2022
1LigandsIBA
07/2022
1pamiparibIBA
01/2022
1famitinibIBA
01/2022
1camrelizumabIBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
10/2021
1Cadmium Chloride (Cadmium Dichloride)IBA
04/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1AntigensIBA
01/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1RacivirIBA
09/2020
1ZincIBA
05/2020
1Messenger RNA (mRNA)IBA
01/2020
1Potassium Channels (Potassium Channel)IBA
01/2019
1Long Noncoding RNAIBA
01/2019
1CarbohydratesIBA
10/2018
1EnzymesIBA
10/2018
1Indicators and Reagents (Reagents)IBA
06/2017
1Dihydrotachysterol (AT 10)IBA
10/2015
1HLA-DQB1 antigen (HLA DQB1)IBA
07/2015
1HLA Antigens (Human Leukocyte Antigens)IBA
07/2015
116S Ribosomal RNAIBA
10/2014
1DNA (Deoxyribonucleic Acid)IBA
04/2013
1StathminIBA
04/2013

Therapy/Procedure

10Drug Therapy (Chemotherapy)
01/2022 - 04/2013
6Therapeutics
01/2022 - 01/2017
4Cytoreduction Surgical Procedures
01/2022 - 04/2013
1Immunotherapy
01/2022
1Radiotherapy
10/2021
1Brachytherapy
10/2021
1Chemoradiotherapy
10/2021
1Neoadjuvant Therapy
09/2020
1Lymph Node Excision (Lymph Node Dissection)
01/2017
1Hysterectomy
01/2017
1Punctures
10/2015
1Salpingo-oophorectomy
10/2015